Back to search

Article

Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and gatekeeper features

2022-11-15

Abstract excerpt

<h4>ABSTRACT</h4> Due to its stimulatory potential for immunomodulatory CD4 + regulatory T (Treg) cells, low-dose interleukin-2 (IL-2) immunotherapy has recently gained considerable attention for treatment of various autoimmune diseases. Although early-stage clinical trials have correlated expansion of circulating Treg cells with clinical response to IL-2 treatment, detailed mechanistic data on responding Treg cel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b04cde8e-8ec8-5a1b-aa26-1fe725be77a8
DOI
10.1101/2022.11.15.22282201
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and gatekeeper featuresDOI 10.1101/2022.11.15.22282201
Select a neighboring publication to make it the new centre.